The U.S. Food and Drug Administration on Thursday approved Gilead Sciences Inc’s antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first and only drug approved for the disease in the United States. Remdesivir, given intravenously, was one of the drugs used to treat U.S. President Donald Trump during his bout with […]
The post Gilead’s remdesivir gets U.S. FDA approval for hospitalized COVID-19 patients appeared first on Interaksyon.
Post a Comment